KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesBeginning Cash BalanceCash from Financing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Esperion Therapeutics (ESPR) Non-cash Items: 2018-2019

Historic Non-cash Items for Esperion Therapeutics (ESPR) over the last 2 years, with Dec 2019 value amounting to $109.1 million.

  • Esperion Therapeutics' Non-cash Items rose 3.17% to $3.2 million in Q2 2020 from the same period last year, while for Jun 2020 it was $3.2 million, marking a year-over-year increase of 3.17%. This contributed to the annual value of $109.1 million for FY2019, which is 30.65% up from last year.
  • Per Esperion Therapeutics' latest filing, its Non-cash Items stood at $109.1 million for FY2019, which was up 30.65% from $83.5 million recorded in FY2018.
  • Over the past 5 years, Esperion Therapeutics' Non-cash Items peaked at $109.1 million during FY2019, and registered a low of $83.5 million during FY2018.
  • In the last 2 years, Esperion Therapeutics' Non-cash Items had a median value of $96.3 million in 2018 and averaged $96.3 million.
  • Data for Esperion Therapeutics' Non-cash Items shows a peak YoY soared of 30.65% (in 2019) over the last 5 years.
  • Yearly analysis of 2 years shows Esperion Therapeutics' Non-cash Items stood at $83.5 million in 2018, then soared by 30.65% to $109.1 million in 2019.